Not exact matches
Kirsch's team considered how
sick each group of
patients had been before treatment, how much they
improved during treatment, and whether they'd gotten a real drug or an inert pill.
Once they found that the OTULIN gene was abnormal in the
sick children, they studied the immune pathway in order to understand the mechanisms of disease and to
improve treatment of these
patients.
The Guided Care model was developed by a team of researchers at the Bloomberg School, the Johns Hopkins School of Nursing and the Johns Hopkins School of Medicine and is designed to
improve patients» quality of life and care, while
improving the efficiency of treating the
sickest and most complex
patients.
«We've come a long way in
improving our survival rates of these
patients but what we didn't know was whether we were returning them to their homes and communities
sicker than they were before.»
Their influence in contributing to the
improved outlook of
sick and terminally ill
patients is undeniable.